MedPath

Different doses of Regular Insulin in Diabetic Ketoacidosis

Not Applicable
Conditions
Health Condition 1: E101- Type 1 diabetes mellitus with ketoacidosis
Registration Number
CTRI/2021/12/038790
Lead Sponsor
pgims rohtak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diabetis Mellitus type 1 with Diabetic Ketoacidosis having hyperglycemia, acidosis and ketonuria

Exclusion Criteria

Symptomatic cerebral edema, septic shock, anuia more than 6 hour, insulin taken before admission

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lowering of blood glucoseTimepoint: At first, second, third and fourth hour of intravenous Regular Insulin administration and time taken in resolution Diabetic Resolution
Secondary Outcome Measures
NameTimeMethod
hypokalemia and hypoglycemiaTimepoint: 0-1 hr, 1-2 hr, 2-3 hr, 3-4 hr
© Copyright 2025. All Rights Reserved by MedPath